Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

The Contribution of CD148, CD180 and CD200 Combination in the Diagnosis of Chronic B-Cell Lymphoproliferative Disorders

Laurent Miguet, Caroline Mayeur-Rousse, Alice Eischen, Anne-Cecile Galoisy, Delphine C. M. Rolland, Carine Gervais, Eric Jeandidier, Raoul Herbrecht, Luc-Matthieu Fornecker, Thibaut Fabacher, Razvan Bizoi, Laurent Mauvieux

Blood (2021) 138 (Supplement 1): 3520.

https://doi.org/10.1182/blood-2021-150810

Published: 2021

Journal Articles

A Core Proliferative Program Induced By B-Cell Receptor Stimulation in Chronic Lymphocytic Leukemia Cells

Cédric Schleiss, Raphael Carapito, PhD, Luc Mathieu Fornecker, MD PhD, Leslie Muller, Paul Nicodeme, Ouria Tahar, Angélique Pichot, BSc, Laurent Mauvieux, MD PhD, Raoul Herbrecht, MD, Myriam Maumy-Bertrand, Jean-Noel Freund, Christine Carapito, Seiamak Bahram, MD, Frederic Bertrand, Laurent Vallat, MD PhD

Blood (2019) 134 (Supplement_1): 3777.

https://doi.org/10.1182/blood-2019-126779

Published: 2019

Journal Articles

ZAP-70 Expression in Non Tumoral B Cells: Role in B Tolerance Breakdown?

Mickaël Martin, MD PhD, Anne Marie Knapp, Dana Ghergus, MD PhD, Fabien Delmotte, Laurent Vallat, MD PhD, Cédric Schleiss, Raoul Herbrecht, MD, Anne-Sophie Korganow, MD PhD, Frédéric Gros, PhD, Sophie Jung, DMD, PhD, Pauline Soulas-Sprauel, PharmD, PhD, Eric Meffre, PhD, Thierry Martin, MD PhD

Blood (2018) 132 (Supplement 1): 1114.

https://doi.org/10.1182/blood-2018-99-118237

Published: 2018

Journal Articles

A Percentage of Normal B Cells from CLL Patients Express ZAP-70, Which Is Associated with Autoimmunity and Could be Responsible for Arising of Malignant Clone

Dana Ghergus, Anne-Marie Knapp, Fabien Delmotte, Mickael Martin, MD, Sophie Jung, PhD, Jean-Nicolas Schickel, PhD, Bernard Drenou, MD, Raoul Herbrecht, MD, Jean-Louis Pasquali, MD PhD, Anne-Sophie Korganow, MD PhD, Laurent Daniel Vallat, MD PhD, Pauline Soulas-Sprauel, PhD, Eric Meffre, PhD, Thierry Martin, MD PhD

Blood (2017) 130 (Supplement 1): 2988.

https://doi.org/10.1182/blood.V130.Suppl_1.2988.2988

Published: 2017

Journal Articles

Germline Mutations Occurring Outside the Negatively Charged Amino Acid Stretches of the Exon 9 of Calr : A Predisposition to Hematological Malignancies?

Laurent Miguet, PhD, Carine Gervais, MD, Antoine Ittel, PharmD, Eric Jeandidier, MD, Anne Galoisy, PharmD, Caroline Mayeur-Rousse, MD, Laurie Monier, PharmD, Alice Eischen, PharmD, Laurent Daniel Vallat, MD PhD, Mario Ojeda, MD, Bernard Drenou, MD, Shanti Ame, MD, Raoul Herbrecht, MD, Laurent Mauvieux, MD PhD

Blood (2017) 130 (Supplement 1): 1646.

https://doi.org/10.1182/blood.V130.Suppl_1.1646.1646

Published: 2017

Journal Articles

Evaluation of Progression-Free Survival (PFS) As a Surrogate Endpoint for Overall Survival (OS) in First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Findings from the Surrogate Endpoint in Aggressive Lymphoma (SEAL) Analysis of Individual Patient Data from 7507 Patients

Qian Shi, PhD, Norbert Schmitz, MD, PhD, Christopher Flowers, MD MS, Fang-Shu Ou, PhD, David Cunningham, Michael Pfreundschuh, MD, John F Seymour, Ulrich Jaeger, Thomas M. Habermann, MD, Corinne Haioun, MD PhD, Hervé Tilly, MD PhD, Herve Ghesquieres, MD PhD, Francesco Merli, Marita Ziepert, Raoul Herbrecht, MD, Jocelyne Flament, MD, Tommy Fu, PhD, Bertrand Coiffier, MD PhD, Daniel Sargent, PhD

Blood (2016) 128 (22): 4196.

https://doi.org/10.1182/blood.V128.22.4196.4196

Published: 2016

Journal Articles

Utility of Progression-Free Survival at 24 Months (PFS24) to Predict Subsequent Outcome for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Enrolled on Randomized Clinical Trials: Findings from a Surrogate Endpoint in Aggressive Lymphoma (SEAL) Analysis of Individual Patient Data from 5853 Patients

Blood (2016) 128 (22): 3027.

https://doi.org/10.1182/blood.V128.22.3027.3027

Published: 2016

Journal Articles

Multicentric Analyses of the CD148, CD180, and CD200 Combination for the Diagnosis of Mature B-Cell Neoplasm Using Flow Cytometry

Laurent Miguet, PhD, Luc Fornecker, MD, Marie Wyrwas, Sarah Cianferani, Raoul Herbrecht, MD, Jean-Francois Leseve, Veronique Latger-Cannard, Caroline Mayeur-Rousse, MD, Laurent Mauvieux, MD PhD

Blood (2015) 126 (23): 2662.

https://doi.org/10.1182/blood.V126.23.2662.2662

Published: 2015

Journal Articles

Interest of the CD148, CD180 and CD200 Combination in Flow Cytometry Analyses for Mature B-Cell Neoplasms Diagnosis

Laurent Miguet, PhD, Caroline Mayeur-Rousse, MD, Sarah Lennon, Luc Fornecker, MD, Carine Gervais, MD, Antoine Ittel, PharmD, Anne-Cécile Galoisy, PharmD, Alice Eischen, PharmD, Jean-francois Lesseve, MD, Veronique Latger-Cannard, MD, Raoul Herbrecht, MD, Sarah Cianferani, Laurent Mauvieux, MD PhD

Blood (2014) 124 (21): 5407.

https://doi.org/10.1182/blood.V124.21.5407.5407

Published: 2014

Journal Articles

Updated Efficacy and Safety, and Exploratory Ki-67 Results For The MCL-001 Study Of Lenalidomide In Mantle Cell Lymphoma Patients Who Relapsed Or Were Refractory To Bortezomib

Andre Goy, MD, Michael E. Williams, MD, ScM, Sevgi Kalayoglu Besisik, MD, Johannes Drach, Radhakrishnan Ramchandren, MD, Michael J. Robertson, MD, Irit Avivi, MD, Jacob M Rowe, MD, Raoul Herbrecht, MD, Achiel Van Hoof, Miklos Egyed, Lei Zhang, Sherri Cicero, Tommy Fu, Carla Heise, PhD, Thomas E Witzig, MD

Blood (2013) 122 (21): 3057.

https://doi.org/10.1182/blood.V122.21.3057.3057

Published: 2013

Journal Articles

Comparative Effectiveness and Safety Of Pathogen Inactivated (Amotosalen-UVA) and Conventional Plasma For Treatment Of Auto-Immmune Thrombotic Thrombocytopenic Purpura (TTP): A 15-Year Retrospective Review

Raoul Herbrecht, MD, Mario Ojeda-Uribe, MD, Daniel Kientz, MD, Alain Bohbot, MD, Olivier Hinschberger, MD, Cecile Fohrer, MD, Kun-Lun Liu, MD, Emilie Remy, Christine Ernst, MD, Laurence Corash, MD, Jean-Pierre Cazenave, MD, PhD

Blood (2013) 122 (21): 4820.

https://doi.org/10.1182/blood.V122.21.4820.4820

Published: 2013

Journal Articles

Strong Cell Surface Expression of the Toll-Like Receptor Homolog CD180 Identifies Circulating Cells of Marginal Zone Lymphoma From Other B-Cell Malignancies

Laurent Miguet, Lucile Baseggio, Sarah Lennon, Pascale Felman, Luc Fornecker, Anne-Cecile Galoisy, Caroline Mayeur-Rousse, Raoul Herbrecht, Alice Eischen, Sarah Cianferani, Laurent Mauvieux

Blood (2012) 120 (21): 1542.

https://doi.org/10.1182/blood.V120.21.1542.1542

Published: 2012

Journal Articles

Ruxolitinib Therapy in Myelofibrosis: Analysis of 241 Patients Treated in Compassionate Use (French “ATU” program) by the French Intergroup of Myeloproliferative Neoplasms (FIM).

Blood (2012) 120 (21): 2841.

https://doi.org/10.1182/blood.V120.21.2841.2841

Published: 2012

Journal Articles

Addition of Rituximab Improves Outcome of HIV Negative Patients with Burkitt Lymphoma Treated with the Lmba Protocol: Results of the Randomized Intergroup (GRAALL-Lysa) LMBA02 Protocol. (IGR sponsored LMBA02, NCT00180882)

Vincent Ribrag, MD, Serge Koscielny, ph.D., Krimo Bouabdallah, Service, d'hématologie, clinique, et, de, thérapie, cellulaire, Gilles Salles, MD, Olivier Casasnovas, Christian Recher, MD, Remy Gressin, MD, Jérome Cornillon, M.D., Raoul Herbrecht, MD, Sylviane Iacobelli, Jacques Bosq, M.D., Bertrand Coiffier, MD, PhD

Blood (2012) 120 (21): 685.

https://doi.org/10.1182/blood.V120.21.685.685

Published: 2012

Journal Articles

Phase II Multicenter Study of Single-Agent Lenalidomide in Subjects with Mantle Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: The MCL-001 “EMERGE” Study

Andre Goy, MD, Rajni Sinha, MD, MRCP, Michael E. Williams, M.D., Sevgi Kalayoglu Besisik, Johannes Drach, Radhakrishnan Ramchandren, MD, Michael J. Robertson, MD, Irit Avivi, MD, Jacob M. Rowe, Raoul Herbrecht, MD, Achiel Van Hoof, Miklos Egyed, MD, PhD, Lei Zhang, MD, Sherri Cicero, Tommy Fu, Thomas E. Witzig, MD

Blood (2012) 120 (21): 905.

https://doi.org/10.1182/blood.V120.21.905.905

Published: 2012

Journal Articles

CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study

Raoul Herbrecht, David MacDonald, MD, FRCPC, Florian Weissinger, MD, Martin Wilhelm, MD, Charles Holladay, MS, MD, Nam H. Dang, MD, PhD, Peter Holman, MD, Paul Cernohous, MS, Jack Singer, MD, Richard H. van der Jagt, MD, FRCPC

Blood (2011) 118 (21): 1605.

https://doi.org/10.1182/blood.V118.21.1605.1605

Published: 2011

Journal Articles

A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia

Aurore Perrot, Cédric Pionneau, Sophie Nadaud, Frédéric Davi, Véronique Leblond, Frédéric Jacob, Hélène Merle-Béral, Raoul Herbrecht, Marie-Christine Béné, John G. Gribben, Seiamak Bahram, Laurent Vallat

Blood (2011) 118 (4): e1–e15.

https://doi.org/10.1182/blood-2011-02-335125

Published: 2011

Includes: Supplemental data

Journal Articles

Zygomycosis After Allogeneic Hematopoietic Stem Cell Transplantation: A French Multicenter Cohort Study (2003-2008)

Alienor Xhaard, Fanny Fanternier, Eric Dannaoui, Anne Bergeron-Lafaurie, Claire Lacroix, Raoul Herbrecht, Faezeh Legrand, Mohamad Mohty, Mauricette Michallet, Catherine Cordonnier-Carlet, Sandra Malak, Denis Guyotat, Louis Jean Couderc, Gerard Socie, Olivier Lortholary, Patricia Ribaud

Blood (2010) 116 (21): 1263.

https://doi.org/10.1182/blood.V116.21.1263.1263

Published: 2010

Journal Articles

Bendamustine Induces Higher Remission Rates, Prolongs Progression Free Survival as Well as Time to Next Treatment, and Improves Overall Survival for Patients In Complete Remission without Compromising Quality of Life When Compared to Chlorambucil In First Line Treatment of Chronic Lymphocytic Leukemia

Wolfgang Ulrich Knauf, MD, Toshko Lissitchkov, MD, Ali Aldaoud, MD, Anna Marina Liberati, MD, Javier Loscertales, MD, Raoul Herbrecht, Gunnar Juliusson, MD, Gerhard Postner, MD, Liana Gercheva, MD, Stefan Goranov, MD, Martin Becker, MD, Hans-Joerg Fricke, MD, Françoise Huguet, MD, Ilaria Del Guidice, MD, Peter Klein, Karlheinz Merkle, MD, Marco Montillo

Blood (2010) 116 (21): 2449.

https://doi.org/10.1182/blood.V116.21.2449.2449

Published: 2010

Journal Articles

Flow Cytometry Study of CD148, a Tyrosine Phosphatase Receptor, in 184 Chronic B Cell Malignancies, Reveals a High Expression in Mantle Cell and Marginal Zone Lymphomas.

Laurent Miguet, Luc-Matthieu Fornecker, Estelle Zink, Guillaume Bechade, Raoul Herbrecht, MD, Alain van Dorsselaer, Sarah Sanglier, Laurent Mauvieux, MD, PhD

Blood (2009) 114 (22): 1923.

https://doi.org/10.1182/blood.V114.22.1923.1923

Published: 2009

NARROW

The Contribution of CD148, CD180 and CD200 Combination in the Diagnosis of Chronic B-Cell Lymphoproliferative Disorders

A Core Proliferative Program Induced By B-Cell Receptor Stimulation in Chronic Lymphocytic Leukemia Cells

ZAP-70 Expression in Non Tumoral B Cells: Role in B Tolerance Breakdown?

A Percentage of Normal B Cells from CLL Patients Express ZAP-70, Which Is Associated with Autoimmunity and Could be Responsible for Arising of Malignant Clone

Germline Mutations Occurring Outside the Negatively Charged Amino Acid Stretches of the Exon 9 of Calr : A Predisposition to Hematological Malignancies?

Evaluation of Progression-Free Survival (PFS) As a Surrogate Endpoint for Overall Survival (OS) in First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Findings from the Surrogate Endpoint in Aggressive Lymphoma (SEAL) Analysis of Individual Patient Data from 7507 Patients

Multicentric Analyses of the CD148, CD180, and CD200 Combination for the Diagnosis of Mature B-Cell Neoplasm Using Flow Cytometry

Interest of the CD148, CD180 and CD200 Combination in Flow Cytometry Analyses for Mature B-Cell Neoplasms Diagnosis

Updated Efficacy and Safety, and Exploratory Ki-67 Results For The MCL-001 Study Of Lenalidomide In Mantle Cell Lymphoma Patients Who Relapsed Or Were Refractory To Bortezomib

Comparative Effectiveness and Safety Of Pathogen Inactivated (Amotosalen-UVA) and Conventional Plasma For Treatment Of Auto-Immmune Thrombotic Thrombocytopenic Purpura (TTP): A 15-Year Retrospective Review

Strong Cell Surface Expression of the Toll-Like Receptor Homolog CD180 Identifies Circulating Cells of Marginal Zone Lymphoma From Other B-Cell Malignancies

Ruxolitinib Therapy in Myelofibrosis: Analysis of 241 Patients Treated in Compassionate Use (French “ATU” program) by the French Intergroup of Myeloproliferative Neoplasms (FIM).

Addition of Rituximab Improves Outcome of HIV Negative Patients with Burkitt Lymphoma Treated with the Lmba Protocol: Results of the Randomized Intergroup (GRAALL-Lysa) LMBA02 Protocol. (IGR sponsored LMBA02, NCT00180882)

Phase II Multicenter Study of Single-Agent Lenalidomide in Subjects with Mantle Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: The MCL-001 “EMERGE” Study

CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study

A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia

Zygomycosis After Allogeneic Hematopoietic Stem Cell Transplantation: A French Multicenter Cohort Study (2003-2008)

Flow Cytometry Study of CD148, a Tyrosine Phosphatase Receptor, in 184 Chronic B Cell Malignancies, Reveals a High Expression in Mantle Cell and Marginal Zone Lymphomas.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only